Sutro Biopharma Inc (NASDAQ:STRO) shares are trading lower by 2.8% to $5.18 during Tuesday’s session after the company announced the pricing of an underwritten offering of 14,478,764 shares of its common stock at $5.18 per share, aiming to raise approximately $75 million. The offering, expected to close around April 4, involves all shares being offered by Sutro and is led by both new and existing healthcare-focused institutional investors.
The company plans to utilize the net proceeds, combined with its existing resources, for various purposes including research, clinical and ...
STRO) Stock?>Full story available on Benzinga.com